Literature DB >> 8958052

CD7-negative T cells represent a separate differentiation pathway in a subset of post-thymic helper T cells.

U Reinhold1, L Liu, J Sesterhenn, H Abken.   

Abstract

The absence of CD7 protein and the corresponding mRNA is a stable feature in a subset of normal circulating CD4+ memory T cells. It is still unresolved whether the CD7- subset represents a specific T-cell lineage. Here we show that repeated stimulation of highly purified CD4+ CD45RA+ CD45RO- naive T cells in vitro leads to the development of a distinct memory subset that is defined by the expression versus non-expression of the CD7 antigen. Comparing different T-cell activation pathways (TCR/CD3, CD2), we observed that alternative signals were critically involved in the development of CD4+ CD7- T cells. Peak mean numbers of CD7- memory cells occurred after 3-5 cycles of restimulation in vitro. Naive T cells that had undergone repeated stimulations were harvested and sorted into CD7+ and CD7- subsets. The vast majority (> 97%) of CD7+ T cells retained their expression, whereas the CD7- population did not re-express the antigen during further propagation of separated T-cell subsets. In CD7- cells no CD7 mRNA was monitored, indicating transcriptional regulation of CD7 expression. Certain differentiation-related antigens, including the cutaneous lymphocyte antigen CLA, were preferentially expressed on CD7- T cells. We suggest that absence of CD7 expression in a subset of CD4+ memory cells reflects a separate and stable differentiation state occurring late in the immune response. These T cells may represent the physiological counterpart of malignant T cells in certain forms of cutaneous T-cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8958052      PMCID: PMC1456566          DOI: 10.1046/j.1365-2567.1996.d01-744.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

1.  High gradient magnetic cell separation with MACS.

Authors:  S Miltenyi; W Müller; W Weichel; A Radbruch
Journal:  Cytometry       Date:  1990

2.  Tyrosine kinase activity associated with the CD7 antigen: correlation with regulation of T cell integrin function.

Authors:  A S Chan; P J Reynolds; Y Shimizu
Journal:  Eur J Immunol       Date:  1994-11       Impact factor: 5.532

3.  Enhanced responsiveness of human memory T cells to CD2 and CD3 receptor-mediated activation.

Authors:  M E Sanders; M W Makgoba; C H June; H A Young; S Shaw
Journal:  Eur J Immunol       Date:  1989-05       Impact factor: 5.532

4.  HLA-DR-positive leucocyte subpopulations in human skin include dendritic cells, macrophages, and CD7-negative T cells.

Authors:  A L Davis; J L McKenzie; D N Hart
Journal:  Immunology       Date:  1988-12       Impact factor: 7.397

5.  Anti-CD2 (sheep red blood cell receptor) monoclonal antibodies and T cell activation. I. Pairs of anti-T11.1 and T11.2 (CD2 subgroups) are strongly mitogenic for T cells in presence of 12-O-tetradecanoylphorbol 13-acetate.

Authors:  D Olive; M Ragueneau; C Cerdan; P Dubreuil; M Lopez; C Mawas
Journal:  Eur J Immunol       Date:  1986-09       Impact factor: 5.532

6.  CD4+CD45R+ cells are preferentially activated through the CD2 pathway.

Authors:  T Matsuyama; P Anderson; J F Daley; S Schlossman; C Morimoto
Journal:  Eur J Immunol       Date:  1988-09       Impact factor: 5.532

7.  Defective expression of T cell-associated glycoprotein in severe combined immunodeficiency.

Authors:  L K Jung; S M Fu; T Hara; N Kapoor; R A Good
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

8.  A Th0/Th2-like function of CD4+CD7- T helper cells from normal donors and HIV-infected patients.

Authors:  B Autran; E Legac; C Blanc; P Debré
Journal:  J Immunol       Date:  1995-02-01       Impact factor: 5.422

9.  The glyceraldehyde 3 phosphate dehydrogenase gene family: structure of a human cDNA and of an X chromosome linked pseudogene; amazing complexity of the gene family in mouse.

Authors:  A Hanauer; J L Mandel
Journal:  EMBO J       Date:  1984-11       Impact factor: 11.598

10.  Molecular cloning of two CD7 (T-cell leukemia antigen) cDNAs by a COS cell expression system.

Authors:  A Aruffo; B Seed
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

View more
  8 in total

Review 1.  T cell signal transduction and the role of CD7 in costimulation.

Authors:  R Stillwell; B E Bierer
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  CD4+ CD7- T cells: a separate subpopulation of memory T cells?

Authors:  U Reinhold; H Abken
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

3.  CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies.

Authors:  Diogo Gomes-Silva; Madhuwanti Srinivasan; Sandhya Sharma; Ciaran M Lee; Dimitrios L Wagner; Timothy H Davis; Rayne H Rouce; Gang Bao; Malcolm K Brenner; Maksim Mamonkin
Journal:  Blood       Date:  2017-05-24       Impact factor: 22.113

4.  Accumulation of CD4+CD7- T cells in inflammatory skin lesions: evidence for preferential adhesion to vascular endothelial cells.

Authors:  L Liu; H Abken; C Pföhler; G Rappl; W Tilgen; U Reinhold
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

5.  A stable aberrant immunophenotype characterizes nearly all cases of cutaneous T-cell lymphoma in blood and can be used to monitor response to therapy.

Authors:  LaBaron T Washington; Yang O Huh; Linda C Powers; Madeleine Duvic; Dan Jones
Journal:  BMC Clin Pathol       Date:  2002-12-10

6.  Novel CD7-specific nanobody-based immunotoxins potently enhanced apoptosis of CD7-positive malignant cells.

Authors:  Jinle Tang; Jialu Li; Xuejun Zhu; Yuan Yu; Dan Chen; Lei Yuan; Zhenyang Gu; Xingding Zhang; Lin Qi; Zhishu Gong; Pengjun Jiang; Juhua Yu; Huimin Meng; Gangli An; Huyong Zheng; Lin Yang
Journal:  Oncotarget       Date:  2016-06-07

7.  An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies.

Authors:  Matthew L Cooper; Jaebok Choi; Karl Staser; Julie K Ritchey; Jessica M Devenport; Kayla Eckardt; Michael P Rettig; Bing Wang; Linda G Eissenberg; Armin Ghobadi; Leah N Gehrs; Julie L Prior; Samuel Achilefu; Christopher A Miller; Catrina C Fronick; Julie O'Neal; Feng Gao; David M Weinstock; Alejandro Gutierrez; Robert S Fulton; John F DiPersio
Journal:  Leukemia       Date:  2018-02-20       Impact factor: 11.528

8.  Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load.

Authors:  Alexandre Harari; Florence Vallelian; Giuseppe Pantaleo
Journal:  Eur J Immunol       Date:  2004-12       Impact factor: 5.532

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.